dc.contributor.author
Riba Baqués, Marta
dc.contributor.author
Valle i Macià, Jaume del
dc.contributor.author
Molina Porcel, Laura
dc.contributor.author
Pelegrí i Gabaldà, Carme
dc.contributor.author
Vilaplana i Hortensi, Jordi
dc.date.issued
2023-01-26T08:06:20Z
dc.date.issued
2023-01-26T08:06:20Z
dc.date.issued
2022-11-21
dc.date.issued
2023-01-26T08:06:20Z
dc.identifier
https://hdl.handle.net/2445/192640
dc.description.abstract
In different organs and tissues, the lymphatic system serves as a drainage system for interstitial fluid and is useful for removing substances that would otherwise accumulate in the interstitium. In the brain, which lacks lymphatic circulation, the drainage and cleaning function is performed by the glymphatic system, called so for its dependence on glial cells and its similar function to that of the lymphatic system. In the present article, we define glymphatic insufficiency as the inability of the glymphatic system to properly perform the brain cleaning function. Furthermore, we propose that corpora amylacea or wasteosomes, which are protective structures that act as waste containers and accumulate waste products, are, in fact, a manifestation of chronic glymphatic insufficiency. Assuming this premise, we provide an explanation that coherently links the formation, distribution, structure, and function of these bodies in the human brain. Moreover, we open up new perspectives in the study of the glymphatic system since wasteosomes can provide information about which variables have the greatest impact on the glymphatic system and which diseases occur with chronic glymphatic insufficiency. For example, based on the presence of wasteosomes, it seems that aging, sleep disorders, and cerebrovascular pathologies have the highest impact on the glymphatic system, whereas neurodegenerative diseases have a more limited impact. Furthermore, as glymphatic insufficiency is a risk factor for neurodegenerative diseases, information provided by wasteosomes could help to define the strategies and actions that can prevent glymphatic disruptions, thus limiting the risk of developing neurodegenerative diseases.
dc.format
application/pdf
dc.format
application/pdf
dc.publisher
National Academy of Sciences
dc.relation
Versió postprint del document publicat a: https://www.pnas.org/doi/10.1073/pnas.2211326119; https://www.pnas.org/doi/10.1073/pnas.2211326119
dc.relation
Proceedings of the National Academy of Sciences of the United States of America - PNAS, 2022, vol. 119, num. 48, p. e2211326119
dc.rights
(c) Riba Baques, Marta et al., 2022
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Bioquímica i Fisiologia)
dc.subject
Envelliment cerebral
dc.subject
Malalties neurodegeneratives
dc.subject
Neurodegenerative Diseases
dc.title
Wasteosomes (corpora amylacea) as a hallmark of chronic glymphatic insufficiency
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion